Cookie Consent by Free Privacy Policy Generator


Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.

Have any Questions? +01 123 444 555

Urologischer Nachwuchs | Best Paper


Dr. Mona Kafka | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
Real-world Outcomes and Predictive Biomarkers for 177 Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study

Dr. med. univ. Lukas Scheipner | Medizinische Universität Graz | Universitätsklinik für Urologie
Characteristics of incidental prostate cancer in the United States


Mag. Dr. Melanie Hassler-Di Fratta, Ph.D. | Medizinische Universität Wien | Universitätsklinik für Urologie
Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis

Dr. Nicolai Hübner | Medizinische Universität Wien | Universitätsklinik für Urologie
Feasibility and Optimal Time Point of [68Ga] Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery

Dr. Stephan Brönimann | Medizinische Universität Wien | Universitätsklinik für Urologie
Time trend analysis of incidence of testicular cancer in Austria during the last four decades

Dr. Andrea Katharina Lindner | Medizinische Universität Innsbruck | Universitätsklinik für Urologie
Do we need repeated CT imaging in uncomplicated blunt renal injuries? Experiences of a high-volume urological trauma centre


Dr. Dong-Ho Mun
Difference in Incontinence Pad Use between Patients after Radical Prostatectomy and Cancer-Free Population with Subgroup Analysis for Open vs. Minimally Invasive Radical Prostatectomy: 
A Descriptive Analysis of Insurance Claims-Based Data
Dr. Judith Stangl-Kremser
Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia
Dr. Maximilian Pallauf
Adherence to the EAU Guideline Recommendations for Local Tumor Treatment in Penile Cancer: Results of the European PROspective Penile Cancer Study Group Survey (E-PROPS)
Priv.-Doz. Dr. David D’Andrea
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
Dr. Michael Ladurner
Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
Dr. Gennadi Tulchiner, PhD
The “COVID-19 Pandemic Gap” and Its Influence on Oncologic Outcomes of Bladder Cancer



Dr. David D'Andrea
Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer
Dr. Renate Pichler
Amplification of 7p12 is associated with pathologic nonresponse to neoadjuvant chemotherapy in muscle-invasive bladder cancer
Dr. Andrea Katharina Lindner
Amplification of 7p12 is associated with pathologic nonresponse to neoadjuvant chemotherapy in muscle-invasive bladder cancer


Dr. Andrea Katharina Lindner
Organ‑sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival
Dr. Judith Stangl-Kremser
Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder


Dr. Klaus Eredics
Bladder cancer in nonagenarians: A multicenter study of 123 patients
Dr. Bernhard Grubmüller
PSMA ligand PET/MRI for primary prostate cancer: Staging performance and clinical impact


Dr. Bernhard Grubmüller
68Ga-PSMA 11 Ligand PET Imaging in Patients with Biochemical Recurrence after Radical Prostatectomy – Diagnostic Performance and Impact on Therapeutic Decision Making
Dr. Maximilian Seles
Blood Platelet Volume Represents a Novel Factor in Patients with Non-metastastatic Renal Cell Carcinoma and Improves the Predictive Ability of Established Prognostic Scores


Dr. Klaus Eredics
Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)
Dr. Stephan Seklehner
Does a retrograde pyelography prior to ureteroscopy influence stone-free rates and complication rates in ureteral calculi?


Dr. Tanja Gschliesser
Geschlechtergetrennte Analyse der Österreichischen Zystektomiedatenbank
Dr. Ingrid Schauer
Sinnhaftigkeit der Kathetereinlage im Rahmen eines hochfieberhaften Harnwegsinfekts: eine prospektiv-randomisierte Studie

© 2024. Fortbildungskommission der ÖGU